Pricing Log in Create free account
Friday 6 November 2026 Export IOVA’s income statement to Excel — free account

Iovance Biotherapeutics, Inc.

IOVA Healthcare Biotechnology

Iovance Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $263.5 million, up 60.6% from fiscal 2024.

Revenue
+80.1%
EPS
+80.0%
Free cash flow
+89.7%

Quarter to September 2026, against a year earlier

7.99 0.25 +3.23%
Market cap
$3.5B
P/E
0.0×
Fwd P/E
−18.9×
Dividend yield
—
F-score
4/9
Altman Z
−2.30
Beneish M
−2.46
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Iovance Biotherapeutics, Inc. (IOVA) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Iovance Biotherapeutics, Inc. (IOVA) trades at a EV/Sales of 8.5×. Over the past ten years it has ranged from 0.0× (March 2024) to 1,798× (April 2024); the current reading is higher than 91% of that period. That is below the Biotechnology industry median of 9.0× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.6× (76.78%)
FY2024 11.1× —
FY2023 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 16.8× 246.84%
Jun 2026 4.9× 19.77%
Mar 2026 4.0× 57.01%
Dec 2025 2.6× 31.76%
10 more quarters

Against its own ten years

Low 0.0× High 1,798×
Ten-year median 0.0×
Current reading's percentile 91

EV/Sales against peers

Company EV/Sales
PBLS Parabilis Medicines, Inc. compare n/m
EWTX Edgewise Therapeutics, Inc. compare n/m
IRON Disc Medicine, Inc. compare n/m
ACAD ACADIA Pharmaceuticals Inc. compare 2.2×
IOVA Iovance Biotherapeutics, Inc. 8.5×
TNGX Tango Therapeutics, Inc. compare 34.7×
ABCL AbCellera Biologics Inc. compare 43.5×
XENE Xenon Pharmaceuticals Inc. compare 169×
RLAY Relay Therapeutics, Inc. compare 231×
Biotechnology industry median 9.0×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on IOVA